Carlos Leite
Gründer bei Medicinia Terapias E Biomarcadores Digitais Ltda.
Profil
Carlos Leite is the founder of Medicinia Terapias E Biomarcadores Digitais Ltda, which was founded in 2012.
He is currently working as a Director at Skore Technologies, Inc.
Aktive Positionen von Carlos Leite
| Unternehmen | Position | Beginn |
|---|---|---|
Medicinia Terapias E Biomarcadores Digitais Ltda.
 Medicinia Terapias E Biomarcadores Digitais Ltda. Miscellaneous Commercial ServicesCommercial Services Medicinia Terapias E Biomarcadores Digitais Ltda. The company is based in Porto Alegre, Brazil. provides online medical publications. The Brazilian company was founded in 2012 by Daniel Branco, Vivian Natale, Carlos Leite. | Gründer | 19.07.2012 |
Skore Technologies, Inc.
 Skore Technologies, Inc. Information Technology ServicesTechnology Services Skore Technologies, Inc. operates as a knowledge orchestration engineering platform developed to adapt to the unique needs of each individual. The company is headquartered in São Paulo, Brazil. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Medicinia Terapias E Biomarcadores Digitais Ltda.
Medicinia Terapias E Biomarcadores Digitais Ltda. Miscellaneous Commercial ServicesCommercial Services Medicinia Terapias E Biomarcadores Digitais Ltda. The company is based in Porto Alegre, Brazil. provides online medical publications. The Brazilian company was founded in 2012 by Daniel Branco, Vivian Natale, Carlos Leite. | Commercial Services |
Skore Technologies, Inc.
Skore Technologies, Inc. Information Technology ServicesTechnology Services Skore Technologies, Inc. operates as a knowledge orchestration engineering platform developed to adapt to the unique needs of each individual. The company is headquartered in São Paulo, Brazil. | Technology Services |
